Chapter
2
References
Melnick A, Licht JD. Deconstructing a disease: RARalpha, its fusion partners, and their roles in the 1.
pathogenesis of acute promyelocytic leukemia. Blood 1999;93:3167-3215.
Liu M, Iavarone A, Freedman LP. Transcriptional activation of the human p21(WAF1/CIP1) gene by 2.
retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. J.Biol.Chem. 1996;271:31723-31728.
Bocchia M, Xu Q, Wesley U et al. Modulation of p53, WAF1/p21 and BCL-2 expression during retinoic 3.
acid-induced differentiation of NB4 promyelocytic cells. Leuk.Res. 1997;21:439-447.
Wang ZG, Delva L, Gaboli M et al. Role of PML in cell growth and the retinoic acid pathway. Science 4.
1998;279:1547-1551.
Duprez E, Wagner K, Koch H, Tenen DG. C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid- 5.
induced differentiation of APL cells. EMBO J. 2003;22:5806-5816.
Yamanaka R, Kim GD, Radomska HS et al. CCAAT/enhancer binding protein epsilon is preferentially up- 6.
regulated during granulocytic differentiation and its functional versatility is determined by alternative use of promoters and differential splicing. Proc.Natl.Acad.Sci.U.S.A 1997;94:6462-6467.
Tenen DG. Disruption of differentiation in human cancer: AML shows the way. Nat.Rev.Cancer 7.
2003;3:89-101.
Massari ME, Murre C. Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. 8.
Cell Biol. 2000;20:429-440.
Norton JD. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J.Cell Sci. 9.
2000;113 ( Pt 22):3897-3905.
Hasskarl J, Duensing S, Manuel E, Munger K. The helix-loop-helix protein ID1 localizes to centrosomes 10.
and rapidly induces abnormal centrosome numbers. Oncogene 2004;23:1930-1938.
de CP, Solit DB, Giri D et al. Angiogenesis impairment in Id-defi cient mice cooperates with an Hsp90 11.
inhibitor to completely suppress HER2/neu-dependent breast tumors. Proc.Natl.Acad.Sci.U.S.A 2003;100:12337-12342.
Fong S, Itahana Y, Sumida T et al. Id-1 as a molecular target in therapy for breast cancer cell invasion 12.
and metastasis. Proc.Natl.Acad.Sci.U.S.A 2003;100:13543-13548.
Ruzinova MB, Schoer RA, Gerald W et al. Effect of angiogenesis inhibition by Id loss and the contribution 13.
of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 2003;4:277-289. Sikder H, Huso DL, Zhang H et al. Disruption of Id1 reveals major differences in angiogenesis between 14.
transplanted and autochthonous tumors. Cancer Cell 2003;4:291-299.
Norton JD, Deed RW, Craggs G, Sablitzky F. Id helix-loop-helix proteins in cell growth and differentia- 15.
tion. Trends Cell Biol. 1998;8:58-65.
Begley CG, Aplan PD, Davey MP et al. Chromosomal translocation in a human leukemic stem-cell line 16.
disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript. Proc.Natl.Acad.Sci.U.S.A 1989;86:2031-2035.
Mellentin JD, Smith SD, Cleary ML. lyl-1, a novel gene altered by chromosomal translocation in T cell 17.
leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell 1989;58:77-83.
Mellentin JD, Murre C, Donlon TA et al. The gene for enhancer binding proteins E12/E47 lies at the 18.
t(1;19) breakpoint in acute leukemias. Science 1989;246:379-382.
Dyck JA, Maul GG, Miller WH, Jr. et al. A novel macromolecular structure is a target of the promyelo- 19.
cyte-retinoic acid receptor oncoprotein. Cell 1994;76:333-343.
Koken MH, Puvion-Dutilleul F, Guillemin MC et al. The t(15;17) translocation alters a nuclear body in a 20.
retinoic acid-reversible fashion. EMBO J. 1994;13:1073-1083.
Weis K, Rambaud S, Lavau C et al. Retinoic acid regulates aberrant nuclear localization of PML-RAR 21.
alpha in acute promyelocytic leukemia cells. Cell 1994;76:345-356.
Lanotte M, Martin-Thouvenin V, Najman S et al. NB4, a maturation inducible cell line with t(15;17) 22.
Chapter
2
Glasser L, Fiederlein RL. Functional differentiation of normal human neutrophils. Blood 23.
1987;69:937-944.
Brons PP, Haanen C, Boezeman JB et al. Proliferation patterns in acute myeloid leukemia: leukemic 24.
clonogenic growth and in vivo cell cycle kinetics. Ann.Hematol. 1993;66:225-233.
Ruzinova MB, Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 25.
2003;13:410-418.
Yan W, Young AZ, Soares VC et al. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double- 26.
knockout mice. Mol.Cell Biol. 1997;17:7317-7327.
Yokota Y, Mansouri A, Mori S et al. Development of peripheral lymphoid organs and natural killer cells 27.
depends on the helix-loop-helix inhibitor Id2. Nature 1999;397:702-706.
Zhuang Y, Soriano P, Weintraub H. The helix-loop-helix gene E2A is required for B cell formation. Cell 28.
1994;79:875-884.
Morrow MA, Mayer EW, Perez CA, Adlam M, Siu G. Overexpression of the Helix-Loop-Helix protein Id2 29.
blocks T cell development at multiple stages. Mol.Immunol. 1999;36:491-503.
Peverali FA, Ramqvist T, Saffrich R et al. Regulation of G1 progression by E2A and Id helix-loop-helix 30.
proteins. EMBO J. 1994;13:4291-4301.
Engel I, Murre C. E2A proteins enforce a proliferation checkpoint in developing thymocytes. EMBO J. 31.
2004;23:202-211.
Rutherford MN, LeBrun DP. Restricted expression of E2A protein in primary human tissues correlates with 32.
proliferation and differentiation. Am.J.Pathol. 1998;153:165-173.
Zhao F, Vilardi A, Neely RJ, Choi JK. Promotion of cell cycle progression by basic helix-loop-helix E2A. 33.
Mol.Cell Biol. 2001;21:6346-6357.
Xin XQ, Nelson C, Collins L, Dorshkind K. Kinetics of E2A basic helix-loop-helix-protein expression during 34.
myelopoiesis and primary B cell differentiation. J.Immunol. 1993;151:5398-5407.
Voronova AF, Lee F. The E2A and tal-1 helix-loop-helix proteins associate in vivo and are modulat- 35.
ed by Id proteins during interleukin 6-induced myeloid differentiation. Proc.Natl.Acad.Sci.U.S.A 1994;91:5952-5956.
Ishiguro A, Spirin KS, Shiohara M et al. Id2 expression increases with differentiation of human myeloid 36.
cells. Blood 1996;87:5225-5231.
Cooper CL, Newburger PE. Differential expression of Id genes in multipotent myeloid progenitor cells: 37.
Id-1 is induced by early-and late-acting cytokines while Id-2 is selectively induced by cytokines that drive terminal granulocytic differentiation. J.Cell Biochem. 1998;71:277-285.
Sikder HA, Devlin MK, Dunlap S, Ryu B, Alani RM. Id proteins in cell growth and tumorigenesis. Cancer 38.
Cell 2003;3:525-530.
Wadman IA, Osada H, Grutz GG et al. The LIM-only protein Lmo2 is a bridging molecule assembling an 39.
erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J. 1997;16:3145-3157.
Lister JA, Baron MH. Induction of basic helix-loop-helix protein-containing complexes during erythroid 40.
differentiation. Gene Expr. 1998;7:25-38.
Cammenga J, Mulloy JC, Berguido FJ et al. Induction of C/EBPalpha activity alters gene expression and 41.
differentiation of human CD34+ cells. Blood 2003;101:2206-2214.
Hui EK, Yung BY. Cell cycle phase-dependent effect of retinoic acid on the induction of granulocytic 42.
differentiation in HL-60 promyelocytic leukemia cells. Evidence for sphinganine potentiation of retinoic acid-induced differentiation. FEBS Lett. 1993;318:193-199.
S van Wageningen, MC Breems-de Ridder, J Nigten, G Nikoloski,
CAJ Erpelinck-Verschueren, B Löwenberg, T de Witte, DG Tenen, BA van der Reijden and JH Jansen
Accepted for publication in Blood